600572 Stock Overview
Engages in the research and development, manufacturing, and sales of medicines and general health products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Zhejiang CONBA Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.62 |
| 52 Week High | CN¥5.59 |
| 52 Week Low | CN¥3.91 |
| Beta | 0.40 |
| 11 Month Change | -1.49% |
| 3 Month Change | 12.41% |
| 1 Year Change | -15.54% |
| 33 Year Change | 10.53% |
| 5 Year Change | -25.48% |
| Change since IPO | -28.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600572 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.3% | -0.6% | -2.8% |
| 1Y | -15.5% | -8.7% | 2.0% |
Return vs Industry: 600572 underperformed the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 600572 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 600572 volatility | |
|---|---|
| 600572 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600572 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600572's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 8,411 | Guoliang Luo | www.conbagroup.com |
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China. It offers Chinese herbal decoction pieces, Chinese patent medicines, chemical pharmaceutical products, chemical raw materials, medical devices, and biological products.
Zhejiang CONBA Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600572 fundamental statistics | |
|---|---|
| Market cap | CN¥11.58b |
| Earnings (TTM) | CN¥486.79m |
| Revenue (TTM) | CN¥6.46b |
23.8x
P/E Ratio1.8x
P/S RatioIs 600572 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600572 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.46b |
| Cost of Revenue | CN¥3.09b |
| Gross Profit | CN¥3.37b |
| Other Expenses | CN¥2.88b |
| Earnings | CN¥486.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 52.14% |
| Net Profit Margin | 7.53% |
| Debt/Equity Ratio | 6.2% |
How did 600572 perform over the long term?
See historical performance and comparison